CJC-1295
CJC-1295 is a synthetic 30-amino-acid GHRH analogue researched for its role in pulsatile growth hormone release, IGF-1 and recovery pathways. Published research protocols most commonly report subcutaneous administration of 1–2 mg 2–3 times weekly for the non-DAC version, or 2 mg once weekly for CJC-1295 with DAC. Lyophilized powder, ≥98% purity, HPLC-verified with per-batch certificate of analysis.
€139.00
In Stock
Details
CJC-1295 is a synthetic 30-amino-acid GHRH analogue researched for its role in pulsatile growth hormone release, IGF-1 and recovery pathways. Published research protocols most commonly report subcutaneous administration of 1–2 mg 2–3 times weekly for the non-DAC version, or 2 mg once weekly for CJC-1295 with DAC. Lyophilized powder, ≥98% purity, HPLC-verified with per-batch certificate of analysis.
98%+ Purity
Third-party lab verified
Cold Chain
Temperature controlled
Fast Shipping
Same-day dispatch
Research Grade
For research use only
Storage
Store refrigerated at 2-8°C. Protect from light. Keep in original packaging until use.
Specifications
Format: Lyophilized powder. Purity: ≥98%. For research use only.
CJC-1295
€139.00
Free shipping within Bulgaria on orders over €150
Same-day dispatch